Oxidative therapies are used for a broad spectrum of health challenges. They are known for their ability to stimulate the body�s immune system. Specifically, they seem to supercharge the white blood cells which are our primary defense against infection. In this day of antibiotic-resistant strains, �new� viruses, and other superbugs, these are low cost and effective solutions that could significantly improve our healthcare. Preferred oxidative therapies include high dose intravenous Vitamin C (IV Vitamin C) and high pressure hyperbaric oxygen chamber, hyperbaric oxygen therapy (HBOT). Because some conditions benefit more from pro-oxidative therapies, and others benefit more from anti-oxidative therapies, it is important to realize that lower dose Vitamin C IVs conversely have an anti-oxidative effect, and low pressure HBOT stimulates the body�s own anti-oxidant production and therefore also has an anti-oxidative effect. Other oxidative therapies include the use of Ozone, Hydrogen Peroxide, or Ultraviolet Blood Irradiation.
Another, a favorite in the fight against viral infections, is the use of magnesium chloride, and also the use of small amounts of very dilute Hydrochloric Acid. Dr. Ruhland and the HBOT chamber Hyperbaric oxygen chamber, hyperbaric oxygen therapy (HBOT) is an oxidative therapy which places patients in an oxygen-rich, pressurized chamber. Breathing pure oxygen under pressure dramatically increases the oxygen in the blood plasma, as well as in the brain, spine, and joint fluid. It is thought that HBOT use is appropriate for any condition where the body�s ability to function and heal would be improved by the presence of extra oxygen. Oxygen therapy has been shown to significantly increase the ability of cells to produce energy. The U.S. Army is currently doing studies on HBOT for traumatic brain injury, as they have found great promise in the treatment of soldiers who have suffered serious head injuries. In the U.S., there are 13 FDA-approved uses for HBOT: Decompression Sickness (deep sea diving)
Enhancement of Healing (in selected problem wounds) Exceptional Blood Loss Anemia Necrotizing Infections (popularly known as �flesh-eating�) Osteomyelitis (bacterial infection of bone or bone marrow) Increasing the oxygen-carrying capacity of the blood has been clearly demonstrated in Europe, Russia and China to improve healing for a wide range of acute and chronic illnesses, which in the U.S. are referred to as �off-label uses.� Worldwide, HBOT successfully treats such diseases as: Brown Recluse Spider Bites Cosmetic Surgery (to improve healing) Heart Disease, Pain and Dysfunction (related to heart attack) Lung Diseases (including inflammation, fibrosis and influenza) Lyme Disease (in conjunction with antibiotic therapy) Macular Degeneration (and other vision problems) Vascular Disorders (including congestion) Ozone treatment is an oxidative therapy which dramatically stimulates tissue healing. It works homeopathically, meaning that it causes inflammation which stimulates the body to produce a powerful anti-inflammatory reaction.
It improves circulation to problem areas and allows the tissue repair process to become much more efficient. Prolozone is an oxidative therapy which utilizes a local anesthetic, Vitamin B12, and folic acid in a base of dilute minerals. It is injected in conjunction with a small amount of ozone. Prolozone appears to stimulate the production of cartilage. This technique is helpful in stopping pain and healing joints and infections, and is most commonly used for pain in the: Chezone is is an oxidative therapy in which chelation therapy is administered after an ozone treatment. There appears to be a synergistic effect, where the combination is more effective than the individual treatments.The IP address used for your Internet connection is part of a subnet that has been blocked from access to PubMed Central. Addresses across the entire subnet were used to download content in bulk, in violation of the terms of the PMC Copyright Notice. Use of PMC is free, but must comply with the terms of the Copyright Notice on the PMC site.
For additional information, or to request that your IP address be unblocked, For requests to be unblocked, you must include all of the information in the box above in your message.This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate The Lancet Publishes CSL Behring’s Kcentra® Phase III Data Kcentra NTAP Extended by CMS Kcentra® Earns FDA Approval for Expanded Indication Kcentra® Study Demonstrates Positive Efficacy and Safety All About Bleeding Website F1000 Posters & Scientific Literature
This content is intended for use by healthcare professionals. In serious bleeding due to excessive warfarin therapy (over-anticoagulation), rapid warfarin (Coumadin) reversal is required. A number of options for warfarin (Coumadin) reversal are available, including: Withdrawal of oral anticoagulants Several healthcare guidelines suggest or recommend PCCs, such as the four-factor PCC manufactured by CSL Behring under the trade names Beriplex® P/N , Confidex® and Kcentra®, as the treatment of choice when normal plasma levels of vitamin K must be urgently restored in a bleeding emergency. In countries where PCC products have the appropriate indication, guidelines similarly recommend use of PCCs before emergency surgery in patients undergoing oral anticoagulation therapy (ie, warfarin, often known as Coumadin). Warfarin reversal is achieved rapidly and completely with PCCs. 7-8 Furthermore, warfarin (Coumadin) reversal is achieved rapidly and completely with prothrombin complex concentrates.
Options for warfarin (Coumadin) reversal Rapid (complete; within 10–15 minutes) Prothrombin complex concentrate (immediate replacement of vitamin K-dependent coagulation factors) plus intravenous vitamin K (to switch on endogenous synthesis of vitamin K-dependent coagulation factors within a few hours) Fresh frozen plasma (immediate replacement of vitamin K-dependent coagulation factors – but the correction of coagulopathy is partial) Prompt (within 4–6 hours) Slow (within 24 hours) Very slow (3–5 days) Omit oral anticoagulation therapy (no vitamin K)Acquired vitamin K coagulation factor deficiencies Deficiency of vitamin K-dependent factors (II [prothrombin], VII, IX and X) Vitamin K antagonist therapy (e.g. oral anticoagulation using warfarin) Oral anticoagulants are used to treat thromboembolic disorders and act by inhibiting vitamin K to prevent the production of coagulation factors, thereby preventing blood clotting.
Their overuse can also cause acquired bleeding. Caused by inadequate diet or malabsorption of vitamin K, which leads to decreased activation of the vitamin K-dependent coagulation factors Hemorrhagic disease of the newborn Coagulation abnormalities in newborns due to vitamin K deficiency. The most common sites of bleeding are the umbilicus mucous membranes, gastrointestinal tract and venipunctures. Results in impaired absorption of vitamin K. Beriplex® P/N (known in some areas as Confidex®) is a prothrombin complex concentrate (PCC) from CSL Behring indicated for: Treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin K antagonists, or in case of overdose of vitamin K antagonists, when rapid correction of the deficiency is needed. Treatment and perioperative prophylaxis of bleedings in congenital deficiency of any of the vitamin K dependent coagulation factors when purified specific coagulation factor products are not available.